{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T17:57:00Z","timestamp":1776621420861,"version":"3.51.2"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,9,4]],"date-time":"2007-09-04T00:00:00Z","timestamp":1188864000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2007,11,8]]},"DOI":"10.1007\/s12016-007-8001-x","type":"journal-article","created":{"date-parts":[[2007,9,3]],"date-time":"2007-09-03T07:50:12Z","timestamp":1188805812000},"page":"265-274","source":"Crossref","is-referenced-by-count":70,"title":["Clinical, Immunologic, and Molecular Factors Predicting Lymphoma Development in Sjogren\u2019s Syndrome Patients"],"prefix":"10.1007","volume":"32","author":[{"given":"Michael","family":"Voulgarelis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotini N.","family":"Skopouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,4]]},"reference":[{"key":"8001_CR1","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0002-9343(64)90101-9","volume":"36","author":"N Talal","year":"1963","unstructured":"Talal N, Bunim JJ (1964) The Development of Malignant Lymphoma in the Course of Sjoegren\u2019s Syndrome. Am J Med 36:529\u2013540","journal-title":"Am J Med"},{"key":"8001_CR2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","volume":"89","author":"SS Kassan","year":"1978","unstructured":"Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR et al (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89:888\u2013892","journal-title":"Ann Intern Med"},{"key":"8001_CR3","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.4049\/jimmunol.130.6.2663","volume":"130","author":"HM Moutsopoulos","year":"1983","unstructured":"Moutsopoulos HM, Steinberg AD, Fauci AS, Lane HC, Papadopoulos NM (1983) High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren\u2019s syndrome. J Immunol 130:2663\u20132665","journal-title":"J Immunol"},{"key":"8001_CR4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/art.1780290907","volume":"29","author":"AG Tzioufas","year":"1986","unstructured":"Tzioufas AG, Manoussakis MN, Costello R, Silis M, Papadopoulos NM, Moutsopoulos HM (1986) Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjogren\u2019s syndrome. Arthritis Rheum 29:1098\u20131104","journal-title":"Arthritis Rheum"},{"key":"8001_CR5","first-page":"2376","volume":"24","author":"G Valesini","year":"1997","unstructured":"Valesini G, Priori R, Bavoillot D, Osborn J, Danieli MG, Del Papa N et al (1997) Differential risk of non-Hodgkin\u2019s lymphoma in Italian patients with primary Sjogren\u2019s syndrome. J Rheumatol 24:2376\u20132380","journal-title":"J Rheumatol"},{"key":"8001_CR6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJM197811302992204","volume":"299","author":"J Zulman","year":"1978","unstructured":"Zulman J, Jaffe R, Talal N (1978) Evidence that the malignant lymphoma of Sjogren\u2019s syndrome is a monoclonal B-cell neoplasm. N Engl J Med 299:1215\u20131220","journal-title":"N Engl J Med"},{"key":"8001_CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF00443482","volume":"395","author":"U Schmid","year":"1982","unstructured":"Schmid U, Helbron D, Lennert K (1982) Development of malignant lymphoma in myoepithelial sialadenitis (Sjogren\u2019s syndrome). Virchows Arch A Pathol Anat Histol 395:11\u201343","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"8001_CR8","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1084\/jem.174.5.1245","volume":"174","author":"EK Pisa","year":"1991","unstructured":"Pisa EK, Pisa P, Kang HI, Fox RI (1991) High frequency of t(14;18) translocation in salivary gland lymphomas from Sjogren\u2019s syndrome patients. J Exp Med 174:1245\u20131250","journal-title":"J Exp Med"},{"key":"8001_CR9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(98)80040-1","volume":"28","author":"N Sutcliffe","year":"1998","unstructured":"Sutcliffe N, Inanc M, Speight P, Isenberg D (1998) Predictors of lymphoma development in primary Sjogren\u2019s syndrome. Semin Arthritis Rheum 28:80\u201387","journal-title":"Semin Arthritis Rheum"},{"key":"8001_CR10","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165:2337\u20132344","journal-title":"Arch Intern Med"},{"key":"8001_CR11","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","volume":"42","author":"M Voulgarelis","year":"1999","unstructured":"Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM (1999) Malignant lymphoma in primary Sjogren\u2019s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren\u2019s Syndrome. Arthritis Rheum 42:1765\u20131772","journal-title":"Arthritis Rheum"},{"key":"8001_CR12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1182\/blood.V90.2.766","volume":"90","author":"B Royer","year":"1997","unstructured":"Royer B, Cazals-Hatem D, Sibilia J, Agbalika F, Cayuela JM, Soussi T et al (1997) Lymphomas in patients with Sjogren\u2019s syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 90:766\u2013775","journal-title":"Blood"},{"issue":"1\u20132","key":"8001_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/10428199909093729","volume":"33","author":"X Mariette","year":"1999","unstructured":"Mariette X (1999) Lymphomas in patients with Sjogren\u2019s syndrome: review of the literature and physiopathologic hypothesis. Leuk Lymphoma 33(1\u20132):93\u201399","journal-title":"Leuk Lymphoma"},{"key":"8001_CR14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/ajcp\/96.6.738","volume":"96","author":"RJ Pelstring","year":"1991","unstructured":"Pelstring RJ, Essell JH, Kurtin PJ, Cohen AR, Banks PM (1991) Diversity of organ site involvement among malignant lymphomas of mucosa-associated tissues. Am J Clin Pathol 96:738\u2013745","journal-title":"Am J Clin Pathol"},{"key":"8001_CR15","first-page":"1361","volume":"151","author":"A Dogan","year":"1997","unstructured":"Dogan A, Du M, Koulis A, Briskin MJ, Isaacson PG (1997) Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 151:1361\u20131369","journal-title":"Am J Pathol"},{"issue":"1 Suppl 1","key":"8001_CR16","first-page":"S126","volume":"111","author":"NL Harris","year":"1999","unstructured":"Harris NL, Isaacson PG (1999) What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites? Am J Clin Pathol 111(1 Suppl 1):S126\u2013S132","journal-title":"Am J Clin Pathol"},{"key":"8001_CR17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1200\/JCO.1999.17.4.1254","volume":"17","author":"PL Zinzani","year":"1999","unstructured":"Zinzani PL, Magagnoli M, Galieni P, Martelli M, Poletti V, Zaja F et al (1999) Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 17:1254\u20131258","journal-title":"J Clin Oncol"},{"key":"8001_CR18","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","volume":"101","author":"E Zucca","year":"2003","unstructured":"Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK et al (2003) Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 101:2489\u20132495","journal-title":"Blood"},{"issue":"3","key":"8001_CR19","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","volume":"95","author":"C Thieblemont","year":"2000","unstructured":"Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P et al (2000) Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95(3):802\u2013806","journal-title":"Blood"},{"key":"8001_CR20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/1024533021000024058","volume":"7","author":"D Rossi","year":"2002","unstructured":"Rossi D, Gaidano G (2002) Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis. Hematology 7:239\u2013252","journal-title":"Hematology"},{"key":"8001_CR21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00001622-199605000-00011","volume":"8","author":"JA DiGiuseppe","year":"1996","unstructured":"DiGiuseppe JA, Corio RL, Westa WH (1996) Lymphoid infiltrates of the salivary glands: pathology, biology and clinical significance. Curr Opin Oncol 8:232\u2013237","journal-title":"Curr Opin Oncol"},{"key":"8001_CR22","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1172\/JCI3234","volume":"102","author":"DI Stott","year":"1998","unstructured":"Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C (1998) Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjogren\u2019s syndrome. J Clin Invest 102:938\u2013946","journal-title":"J Clin Invest"},{"key":"8001_CR23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.130.1.203","volume":"130","author":"TC Adamson","year":"1983","unstructured":"Adamson TC, Fox RI, Frisman DM, Howell FV (1983) Immunohistologic analysis of lymphoid infiltrates in primary Sjogren\u2019s syndrome using monoclonal antibodies. J Immunol 130:203\u2013208","journal-title":"J Immunol"},{"key":"8001_CR24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/rheumatology\/34.4.326","volume":"34","author":"D Boumba","year":"1995","unstructured":"Boumba D, Skopouli FN, Moutsopoulos HM (1995) Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjogren\u2019s syndrome. Br J Rheumatol 34:326\u2013333","journal-title":"Br J Rheumatol"},{"key":"8001_CR25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ard.49.11.929","volume":"49","author":"HM Moutsopoulos","year":"1990","unstructured":"Moutsopoulos HM, Tzioufas AG, Bai MK, Papadopoulos NM, Papadimitriou CS (1990) Association of serum IgM kappa monoclonicity in patients with Sjogren\u2019s syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands. Ann Rheum Dis 49:929\u2013931","journal-title":"Ann Rheum Dis"},{"key":"8001_CR26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/j.2326-5205.1989.tb00017.x","volume":"32","author":"B Freimark","year":"1989","unstructured":"Freimark B, Fantozzi R, Bone R, Bordin G, Fox R (1989) Detection of clonally expanded salivary gland lymphocytes in Sjogren\u2019s syndrome. Arthritis Rheum 32:859\u2013869","journal-title":"Arthritis Rheum"},{"key":"8001_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ard.44.2.109","volume":"44","author":"HM Moutsopoulos","year":"1985","unstructured":"Moutsopoulos HM, Costello R, Drosos AA, Mavridis AK, Papadopoulos NM (1985) Demonstration and identification of monoclonal proteins in the urine of patients with Sjogren\u2019s syndrome. Ann Rheum Dis 44:109\u2013112","journal-title":"Ann Rheum Dis"},{"key":"8001_CR28","first-page":"247","volume":"6","author":"P Youinou","year":"1988","unstructured":"Youinou P, Papadopoulos NM, Katsikis P, Pennec YL, Jouquan J, Lelong A et al (1988) Monoclonal immunoglobulins in the serum of patients with primary Sjogren\u2019s syndrome. Clin Exp Rheumatol 6:247\u2013252","journal-title":"Clin Exp Rheumatol"},{"key":"8001_CR29","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.md.0000157398.37679.47","volume":"84","author":"P Brito-Zeron","year":"2005","unstructured":"Brito-Zeron P, Ramos-Casals M, Nardi N, Cervera R, Yague J, Ingelmo M et al (2005) Circulating monoclonal immunoglobulins in Sjogren syndrome: prevalence and clinical significance in 237 patients. Medicine (Baltimore) 84:90\u201397","journal-title":"Medicine (Baltimore)"},{"key":"8001_CR30","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood.V91.6.1864","volume":"91","author":"DW Bahler","year":"1998","unstructured":"Bahler DW, Swerdlow SH (1998) Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjogren\u2019s syndrome) begin as nonmalignant antigen-selected expansions. Blood 91:1864\u20131872","journal-title":"Blood"},{"key":"8001_CR31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/art.1780400217","volume":"40","author":"S Vita De","year":"1997","unstructured":"De Vita S, Boiocchi M, Sorrentino D, Carbone A, Avellini C, Dolcetti R et al (1997) Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren\u2019s syndrome. Arthritis Rheum 40:318\u2013331","journal-title":"Arthritis Rheum"},{"issue":"1 Suppl 1","key":"8001_CR32","first-page":"S94","volume":"111","author":"NL Harris","year":"1999","unstructured":"Harris NL (1999) Lymphoid proliferations of the salivary glands. Am J Clin Pathol 111(1 Suppl 1):S94\u2013S103","journal-title":"Am J Clin Pathol"},{"key":"8001_CR33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0049-0172(96)80019-9","volume":"25","author":"JM Anaya","year":"1996","unstructured":"Anaya JM, McGuff HS, Banks PM, Talal N (1996) Clinicopathological factors relating malignant lymphoma with Sjogren\u2019s syndrome. Semin Arthritis Rheum 25:337\u2013346","journal-title":"Semin Arthritis Rheum"},{"key":"8001_CR34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4049\/jimmunol.137.1.122","volume":"137","author":"S Fong","year":"1986","unstructured":"Fong S, Chen PP, Gilbertson TA, Weber JR, Fox RI, Carson DA (1986) Expression of three cross-reactive idiotypes on rheumatoid factor autoantibodies from patients with autoimmune diseases and seropositive adults. J Immunol 137:122\u2013128","journal-title":"J Immunol"},{"key":"8001_CR35","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4049\/jimmunol.136.2.477","volume":"136","author":"RI Fox","year":"1986","unstructured":"Fox RI, Chen P, Carson DA, Fong S (1986) Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren\u2019s syndrome. J Immunol 136:477\u2013483","journal-title":"J Immunol"},{"key":"8001_CR36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2249.1990.tb05481.x","volume":"82","author":"PD Katsikis","year":"1990","unstructured":"Katsikis PD, Youinou PY, Galanopoulou V, Papadopoulos NM, Tzioufas AG, Moutsopoulos HM (1990) Monoclonal process in primary Sjogren\u2019s syndrome and cross-reactive idiotype associated with rheumatoid factor. Clin Exp Immunol 82:509\u2013514","journal-title":"Clin Exp Immunol"},{"key":"8001_CR37","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood.V89.9.3335","volume":"89","author":"DW Bahler","year":"1997","unstructured":"Bahler DW, Miklos JA, Swerdlow SH (1997) Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood 89:3335\u20133344","journal-title":"Blood"},{"key":"8001_CR38","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1182\/blood.V95.12.3878","volume":"95","author":"JA Miklos","year":"2000","unstructured":"Miklos JA, Swerdlow SH, Bahler DW (2000) Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features. Blood 95:3878\u20133884","journal-title":"Blood"},{"key":"8001_CR39","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/1529-0131(200004)43:4<908::AID-ANR24>3.0.CO;2-K","volume":"43","author":"T Martin","year":"2000","unstructured":"Martin T, Weber JC, Levallois H, Labouret N, Soley A, Koenig S et al (2000) Salivary gland lymphomas in patients with Sjogren\u2019s syndrome may frequently develop from rheumatoid factor B cells. Arthritis Rheum 43:908\u2013916","journal-title":"Arthritis Rheum"},{"key":"8001_CR40","first-page":"285","volume":"142","author":"T Hussell","year":"1993","unstructured":"Hussell T, Isaacson PG, Crabtree JE, Dogan A, Spencer J (1993) Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. Am J Pathol 142:285\u2013292","journal-title":"Am J Pathol"},{"key":"8001_CR41","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/eji.1830270723","volume":"27","author":"MM D\u2019Elios","year":"1997","unstructured":"D\u2019Elios MM, Manghetti M, Almerigogna F, Amedei A, Costa F, Burroni D et al (1997) Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 27:1751\u20131755","journal-title":"Eur J Immunol"},{"key":"8001_CR42","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.V92.9.3018","volume":"92","author":"K Gronbaek","year":"1998","unstructured":"Gronbaek K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, Hansen NE et al (1998) Somatic Fas mutations in non-Hodgkin\u2019s lymphoma: association with extranodal disease and autoimmunity. Blood 92:3018\u20133024","journal-title":"Blood"},{"key":"8001_CR43","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/art.1780400113","volume":"40","author":"L Kong","year":"1997","unstructured":"Kong L, Ogawa N, Nakabayashi T, Liu GT, D\u2019Souza E, McGuff HS et al (1997) Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren\u2019s syndrome. Arthritis Rheum 40:87\u201397","journal-title":"Arthritis Rheum"},{"key":"8001_CR44","first-page":"261","volume":"79","author":"H Nakamura","year":"1999","unstructured":"Nakamura H, Kawakami A, Tominaga M, Migita K, Kawabe Y, Nakamura T et al (1999) Expression of CD40\/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjogren\u2019s syndrome. Lab Invest 79:261\u2013269","journal-title":"Lab Invest"},{"key":"8001_CR45","first-page":"339","volume":"17","author":"F Bertolo","year":"1999","unstructured":"Bertolo F, De Vita S, Dolcetti R, Carbone A, Ferraccioli GF, Bartoli E, Boiocchi M (1999) Lack of Fas and Fas-L mutations in patients with lymphoproliferative disorders associated with Sjogren\u2019s syndrome and type II mixed cryoglobulinemia. Clin Exp Rheumatol 17:339\u2013342","journal-title":"Clin Exp Rheumatol"},{"key":"8001_CR46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1023\/A:1008357314157","volume":"1","author":"B Maes","year":"2000","unstructured":"Maes B, Baens M, Marynen P, De Wolf-Peeters C (2000) The product of the t(11;18), an API2-MLT fusion, is an almost exclusive finding in marginal zone cell lymphoma of extranodal MALT-type. Ann Oncol 1:521\u2013526","journal-title":"Ann Oncol"},{"key":"8001_CR47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1470-2045(02)00651-4","volume":"3","author":"MQ Du","year":"2002","unstructured":"Du MQ, Isaccson PG (2002) Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 3:97\u2013104","journal-title":"Lancet Oncol"},{"key":"8001_CR48","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1023\/A:1011122904602","volume":"12","author":"M Raderer","year":"2001","unstructured":"Raderer M, Osterreicher C, Machold K, Formanek M, Fiebiger W, Penz M et al (2001) Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease. Ann Oncol 12:937\u2013939","journal-title":"Ann Oncol"},{"key":"8001_CR49","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1158\/1078-0432.CCR-0873-03","volume":"10","author":"B Streubel","year":"2004","unstructured":"Streubel B, Huber D, Wohrer S, Chott A, Raderer M (2004) Frequency of chromosomal aberrations involving MALT1 in mucosa-associated lymphoid tissue lymphoma in patients with Sjogren\u2019s syndrome. Clin Cancer Res 10:476\u2013480","journal-title":"Clin Cancer Res"},{"key":"8001_CR50","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","volume":"190","author":"F Mackay","year":"1999","unstructured":"Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P et al (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697\u20131710","journal-title":"J Exp Med"},{"key":"8001_CR51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","volume":"62","author":"X Mariette","year":"2003","unstructured":"Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T et al (2003) The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren\u2019s syndrome. Ann Rheum Dis 62:168\u2013171","journal-title":"Ann Rheum Dis"},{"key":"8001_CR52","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.LAB.0000059930.92336.E2","volume":"83","author":"P Szodoray","year":"2003","unstructured":"Szodoray P, Jellestad S, Teague MO, Jonsson R (2003) Attenuated apoptosis of B cell activating factor-expressing cells in primary Sjogren\u2019s syndrome. Lab Invest 83:357\u2013365","journal-title":"Lab Invest"},{"key":"8001_CR53","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4049\/jimmunol.172.2.812","volume":"172","author":"M Batten","year":"2004","unstructured":"Batten M, Fletcher C, Ng LG, Groom J, Wheway J, Laabi Y et al (2004) TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma. J Immunol 172:812\u2013822","journal-title":"J Immunol"},{"key":"8001_CR54","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1002\/art.10679","volume":"46","author":"SL Brown","year":"2002","unstructured":"Brown SL, Greene MH, Gershon SK, Edwards ET, Braun MM (2002) Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum 46:3151\u20133158","journal-title":"Arthritis Rheum"},{"key":"8001_CR55","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/0046-8177(93)90183-H","volume":"24","author":"SM Hsu","year":"1993","unstructured":"Hsu SM, Waldron JW Jr, Hsu PL, Hough AJ Jr (1993) Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol 24:1040\u20131057","journal-title":"Hum Pathol"},{"key":"8001_CR56","first-page":"1674","volume":"22","author":"S Vita De","year":"1995","unstructured":"De Vita S, Dolcetti R, Ferraccioli G, Pivetta B, De Re V, Gloghini A, et al (1995) Local cytokine expression in the progression toward B cell malignancy in Sjogren\u2019s syndrome. J Rheumatol 22:1674\u20131680","journal-title":"J Rheumatol"},{"key":"8001_CR57","first-page":"643","volume":"148","author":"H Peng","year":"1996","unstructured":"Peng H, Chen G, Du M, Singh N, Isaacson PG, Pan L (1996) Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 148:643\u2013648","journal-title":"Am J Pathol"},{"key":"8001_CR58","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1182\/blood.V86.12.4587.bloodjournal86124587","volume":"86","author":"M Du","year":"1995","unstructured":"Du M, Peng H, Singh N, Isaacson PG, Pan L (1995) The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 86:4587\u20134593","journal-title":"Blood"},{"key":"8001_CR59","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0167-5699(96)30019-4","volume":"17","author":"T Soussi","year":"1996","unstructured":"Soussi T (1996) The humoral response to the tumor-suppressor gene-product p53 in human cancer: implications for diagnosis and therapy. Immunol Today 17:354\u2013356","journal-title":"Immunol Today"},{"key":"8001_CR60","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1529-0131(199907)42:7<1466::AID-ANR21>3.0.CO;2-L","volume":"42","author":"NI Tapinos","year":"1999","unstructured":"Tapinos NI, Polihronis M, Moutsopoulos HM (1999) Lymphoma development in Sjogren\u2019s syndrome: novel p53 mutations. Arthritis Rheum 42:1466\u20131472","journal-title":"Arthritis Rheum"},{"key":"8001_CR61","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","volume":"341","author":"R Kuppers","year":"1999","unstructured":"Kuppers R, Klein U, Hansmann ML, Rajewsky K (1999) Cellular origin of human B-cell lymphomas. N Engl J Med 341:1520\u20131529","journal-title":"N Engl J Med"},{"key":"8001_CR62","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/modpathol.3880002","volume":"13","author":"S Ihrler","year":"2000","unstructured":"Ihrler S, Baretton GB, Menauer F, Blasenbreu-Vogt S, Lohrs U (2000) Sjogren\u2019s syndrome and MALT lymphomas of salivary glands: a DNA-cytometric and interphase-cytogenetic study. Mod Pathol 13:4\u201312","journal-title":"Mod Pathol"},{"key":"8001_CR63","first-page":"199","volume":"10","author":"LG Anderson","year":"1972","unstructured":"Anderson LG, Talal N (1972) The spectrum of benign to malignant lymphoproliferation in Sjogren\u2019s syndrome. Clin Exp Immunol 10:199\u2013221","journal-title":"Clin Exp Immunol"},{"key":"8001_CR64","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.1780390508","volume":"39","author":"AG Tzioufas","year":"1996","unstructured":"Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM (1996) Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren\u2019s syndrome. Arthritis Rheum 39:767\u2013772","journal-title":"Arthritis Rheum"},{"key":"8001_CR65","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/ard.45.3.210","volume":"45","author":"MT Walters","year":"1986","unstructured":"Walters MT, Stevenson FK, Herbert A, Cawley MI, Smith JL (1986) Urinary monoclonal free light chains in primary Sjogren\u2019s syndrome: an aid to the diagnosis of malignant lymphoma. Ann Rheum Dis 45:210\u2013219","journal-title":"Ann Rheum Dis"},{"key":"8001_CR66","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","volume":"29","author":"FN Skopouli","year":"2000","unstructured":"Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM (2000) Clinical evolution, and morbidity and mortality of primary Sjogren\u2019s syndrome. Semin Arthritis Rheum 29:296\u2013304","journal-title":"Semin Arthritis Rheum"},{"key":"8001_CR67","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","volume":"46","author":"JP Ioannidis","year":"2002","unstructured":"Ioannidis JP, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren\u2019s syndrome. Arthritis Rheum 46:741\u2013747","journal-title":"Arthritis Rheum"},{"key":"8001_CR68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","volume":"44","author":"M Ramos-Casals","year":"2005","unstructured":"Ramos-Casals M, Brito-Zeron P, Yague J, Akasbi M, Bautista R, Ruano M et al (2005) Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren\u2019s syndrome. Rheumatology (Oxford) 44:89\u201394","journal-title":"Rheumatology (Oxford)"},{"key":"8001_CR69","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","volume":"65","author":"E Theander","year":"2006","unstructured":"Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT (2006) Lymphoma and other malignancies in primary Sjogren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796\u2013803","journal-title":"Ann Rheum Dis"},{"key":"8001_CR70","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","volume":"44","author":"GS Cheema","year":"2001","unstructured":"Cheema GS, Roschke V, Hilbert DM, Stohl W (2001) Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum 44:1313\u20131319","journal-title":"Arthritis Rheum"},{"key":"8001_CR71","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1172\/JCI0214121","volume":"109","author":"J Groom","year":"2002","unstructured":"Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P et al (2002) Association of BAFF\/BLyS overexpression and altered B cell differentiation with Sjogren\u2019s syndrome. J Clin Invest 109:59\u201368","journal-title":"J Clin Invest"},{"key":"8001_CR72","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.10949","volume":"48","author":"AM Jacobi","year":"2003","unstructured":"Jacobi AM, Odendahl M, Reiter K, Bruns A, Burmester GR, Radbruch A et al (2003) Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum 48:1332\u20131342","journal-title":"Arthritis Rheum"},{"key":"8001_CR73","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-3083.2001.00989.x","volume":"54","author":"JO Bohnhorst","year":"2001","unstructured":"Bohnhorst JO, Thoen JE, Natvig JB, Thompson KM (2001) Significantly depressed percentage of CD27+ (memory) B cells among peripheral blood B cells in patients with primary Sjogren\u2019s syndrome. Scand J Immunol 54:421\u2013427","journal-title":"Scand J Immunol"},{"key":"8001_CR74","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1002\/art.10445","volume":"46","author":"A Hansen","year":"2002","unstructured":"Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J et al (2002) Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren\u2019s syndrome. Arthritis Rheum 46:2160\u20132171","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8001-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-007-8001-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-007-8001-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T00:33:46Z","timestamp":1684024426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-007-8001-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,4]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,11,8]]}},"alternative-id":["8001"],"URL":"https:\/\/doi.org\/10.1007\/s12016-007-8001-x","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,4]]}}}